BRIEF-Eiger announces positive phase 2 data with pegylated interferon lambda in hepatitis delta virus infection at the American Association for the Study of Liver Diseases meeting
October 23, 2017 at 08:20 AM EDT
* Eiger announces positive phase 2 interim 24-week data with pegylated interferon lambda in hepatitis delta virus (HDV) infection at the American Association for the Study of Liver Diseases (AASLD) meeting Source text for Eikon: Further company coverage:
